His primary areas of study are Virology, Immunology, Antibody, Immunization and Simian immunodeficiency virus. His Virology study frequently draws connections between adjacent fields such as Epitope. When carried out as part of a general Immunology research project, his work on Virus, Immune system, Immunity and Monoclonal antibody is frequently linked to work in Extramural, therefore connecting diverse disciplines of study.
His Antibody research includes elements of Protein structure, Stereochemistry, Viral protein and Antigen. His work in Immunization covers topics such as Vaccination which are related to areas like Hemagglutinin and Influenza A virus subtype H5N1. His Viral load research includes themes of Viremia and Lentivirus.
Adrian B. McDermott spends much of his time researching Virology, Antibody, Immunology, Virus and Immune system. His Virology research incorporates themes from Epitope and B cell. His research in the fields of Immunization and Monoclonal antibody overlaps with other disciplines such as Severe acute respiratory syndrome coronavirus 2.
Simian immunodeficiency virus, Viral load, Immunity, Immunogenicity and Viremia are among the areas of Immunology where the researcher is concentrating his efforts. As a member of one scientific family, Adrian B. McDermott mostly works in the field of Simian immunodeficiency virus, focusing on Cytotoxic T cell and, on occasion, CD8. Viral replication and Neutralizing antibody are the subjects of his Virus studies.
His primary scientific interests are in Antibody, Virology, Severe acute respiratory syndrome coronavirus 2, Immunology and Neutralization. His Antibody research integrates issues from Viral replication, Cohort, Antigen and Vaccination. He has included themes like Priming, Immunization and Immunity in his Virology study.
His study explores the link between Immunization and topics such as Pneumonia that cross with problems in Viral load and Viral Vaccine. The various areas that Adrian B. McDermott examines in his Neutralization study include Viral envelope, Acute infection, Somatic hypermutation and Naive B cell. He interconnects Epitope, Glycosylation and Glycoprotein, Glycan in the investigation of issues within Virus.
The scientist’s investigation covers issues in Severe acute respiratory syndrome coronavirus 2, Antibody, Virology, 2019-20 coronavirus outbreak and Pandemic. His study in the fields of Autoimmunity, Humoral immunity and Memory B cell under the domain of Antibody overlaps with other disciplines such as Coronavirus. His Virology research includes themes of Immunization and Immunity.
His studies in Immunization integrate themes in fields like Vaccination, Viremia and Pneumonia. His studies deal with areas such as Booster dose, Disease and Vaccine efficacy as well as Neutralizing antibody. Immunology is frequently linked to Older population in his study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Lisa A. Jackson;Evan J. Anderson;Nadine G. Rouphael;Paul C. Roberts.
The New England Journal of Medicine (2020)
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.
Evan J. Anderson;Nadine G. Rouphael;Alicia T. Widge;Lisa A. Jackson.
The New England Journal of Medicine (2020)
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.
Kizzmekia S Corbett;Barbara Flynn;Kathryn E Foulds;Joseph R Francica.
The New England Journal of Medicine (2020)
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.
Alicia T. Widge;Nadine G. Rouphael;Lisa A. Jackson;Evan J. Anderson.
The New England Journal of Medicine (2021)
Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19.
Nicole Doria-Rose;Mehul S. Suthar;Mat Makowski;Sarah O’Connell.
The New England Journal of Medicine (2021)
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection
Rebecca M. Lynch;Eli Boritz;Emily E. Coates;Adam DeZure.
Science Translational Medicine (2015)
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial.
Peter B Gilbert;Peter B Gilbert;David C Montefiori;Adrian B McDermott;Youyi Fong.
Science (2021)
Attenuation of Simian Immunodeficiency Virus SIVmac239 Infection by Prophylactic Immunization with DNA and Recombinant Adenoviral Vaccine Vectors Expressing Gag
Danilo R. Casimiro;Fubao Wang;William A. Schleif;Xiaoping Liang.
Journal of Virology (2005)
Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env
Young Do Kwon;Marie Pancera;Priyamvada Acharya;Ivelin S. Georgiev.
Nature Structural & Molecular Biology (2015)
HIV vaccine design: insights from live attenuated SIV vaccines
Wayne C Koff;Philip R Johnson;David I Watkins;Dennis R Burton.
Nature Immunology (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
National Institute of Allergy and Infectious Diseases
National Institute of Allergy and Infectious Diseases
National Institute of Allergy and Infectious Diseases
National Institutes of Health
National Institute of Allergy and Infectious Diseases
University of Melbourne
National Institute of Allergy and Infectious Diseases
National Institute of Allergy and Infectious Diseases
Vanderbilt University Medical Center
National Institute of Allergy and Infectious Diseases
University of Florence
Aligarh Muslim University
University of Antwerp
University of California, Berkeley
University of Melbourne
AbbVie (United States)
California State University, Long Beach
Duke University
Northeastern University
Universiti Malaysia Terengganu
United States Geological Survey
Colorado State University
Fred Hutchinson Cancer Research Center
Johns Hopkins University
Yale University
Autonomous University of Madrid